These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18188635)

  • 1. First description of three patients with multifocal lymphangiomatosis and protein-losing enteropathy following palliation of complex congenital heart disease with total cavo-pulmonary connection.
    Glöckler M; Severin T; Arnold R; Greiner P; Schwab KO; Uhl M; Schlensak C; Rössler J; Dittrich S
    Pediatr Cardiol; 2008 Jul; 29(4):771-4. PubMed ID: 18188635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First description of three patients with multifocal lymphangiomatosis and protein losing enteropathy following palliation of complex congenital heart disease with total cavo-pulmonary connection.
    McHugh K; Barnacle A; Shah N
    Pediatr Cardiol; 2009 May; 30(4):571-2. PubMed ID: 19322602
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymphatic obstruction and protein-losing enteropathy in patients with congenital heart disease.
    Meadows J; Gauvreau K; Jenkins K
    Congenit Heart Dis; 2008; 3(4):269-76. PubMed ID: 18715461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment.
    Meadows J; Jenkins K
    Cardiol Young; 2011 Aug; 21(4):363-77. PubMed ID: 21349233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal lymphangiomatosis in a 38-year-old female: case report and literature review.
    Lin RY; Zou H; Chen TZ; Wu W; Wang JH; Chen XL; Han QX
    World J Gastroenterol; 2014 Jul; 20(25):8320-4. PubMed ID: 25009412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI of lymphatic abnormalities after functional single-ventricle palliation surgery.
    Dori Y; Keller MS; Fogel MA; Rome JJ; Whitehead KK; Harris MA; Itkin M
    AJR Am J Roentgenol; 2014 Aug; 203(2):426-31. PubMed ID: 24848564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decompression of the thoracic duct: A novel transcatheter approach.
    Smith CL; Hoffman TM; Dori Y; Rome JJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E56-E61. PubMed ID: 31444883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular melody valve placement in a small child with protein losing enteropathy.
    Mallula KK; Kenny D; Hijazi ZM
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):267-70. PubMed ID: 24659117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Protein-losing enteropathy following Fontan operation for a complex heart defect].
    Galal O; Kersten J; Götze H; Stoermer J
    Monatsschr Kinderheilkd; 1984 Nov; 132(11):870-2. PubMed ID: 6513949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation.
    Donnelly JP; Rosenthal A; Castle VP; Holmes RD
    J Pediatr; 1997 Mar; 130(3):474-8. PubMed ID: 9063428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of post-Fontan protein-losing enteropathy. After surgical correction of hemodynamic faults other than high right atrial pressure.
    Ventriglia F; Mundo L; Bosco G; Colloridi V
    Tex Heart Inst J; 1996; 23(3):233-5. PubMed ID: 8885109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cavo-atrio-pulmonary anastomosis].
    Quero Jiménez M; Maître Azcárate MJ; Brito Pérez JM; Pérez de León J; López Zea M; Rubio L; Guereta L
    Rev Esp Cardiol; 1993; 46 Suppl 2():101-18. PubMed ID: 8296042
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein-losing enteropathy resolved by percutaneous intervention.
    Butera G; Marini D; MacDonald ST
    Catheter Cardiovasc Interv; 2011 Oct; 78(4):584-8. PubMed ID: 21805565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-losing enteropathy and the Fontan operation.
    Johnson JN; Driscoll DJ; O'Leary PW
    Nutr Clin Pract; 2012 Jun; 27(3):375-84. PubMed ID: 22516942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-dose spironolactone on protein-losing enteropathy in patients with Fontan palliation of complex congenital heart disease.
    Ringel RE; Peddy SB
    Am J Cardiol; 2003 Apr; 91(8):1031-2, A9. PubMed ID: 12686359
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral budesonide as a therapy for protein-losing enteropathy in patients having undergone Fontan palliation.
    Turner Z; Lanford L; Webber S
    Congenit Heart Dis; 2012; 7(1):24-30. PubMed ID: 22129195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-Losing Enteropathy in Patients With Congenital Heart Disease.
    Itkin M; Piccoli DA; Nadolski G; Rychik J; DeWitt A; Pinto E; Rome J; Dori Y
    J Am Coll Cardiol; 2017 Jun; 69(24):2929-2937. PubMed ID: 28619193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surgery in congenital heart defects: current developments and a few case examples].
    Carrel T
    Praxis (Bern 1994); 1997 Apr; 86(17):704-9. PubMed ID: 9221478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of octreotide to successfully treat protein-losing enteropathy following the Fontan operation.
    John AS; Phillips SD; Driscoll DJ; Warnes CA; Cetta F
    Congenit Heart Dis; 2011; 6(6):653-6. PubMed ID: 21545466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of heparin in the treatment of protein-losing enteropathy after fontan operation for complex congenital heart disease.
    Kelly AM; Feldt RH; Driscoll DJ; Danielson GK
    Mayo Clin Proc; 1998 Aug; 73(8):777-9. PubMed ID: 9703306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.